Mollie E. Chipman

机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0002-8266-8367

发表论文 7 篇 · 总被引 132 次 · h-index 4

代表论文

• Regulation of the error-prone DNA polymerase Polκ by oncogenic signaling and its contribution to drug resistance (2020 · Science Signaling · 被引 44)
• Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression (2021 · Cell stem cell · 被引 43)
• Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence (2024 · Neuron · 被引 30)
• Tumor progression is independent of tumor-associated macrophages in cell lineage–based mouse models of glioblastoma (2023 · Proceedings of the National Academy of Sciences · 被引 14)
• Abstract A39: A therapeutic strategy to inhibit Wnt signaling also reprograms breast tumor-immune cell interactions: Perspectives for conferring immune checkpoint inhibitor susceptibility (2020 · Cancer Immunology Research · 被引 1)
• CHA1: A New Combinatorial Therapy That Reciprocally Regulates Wnt and JAK/STAT/Interferon Signaling to Re-program Breast Tumors and the Tumor-Resident Landscape (2022 · bioRxiv (Cold Spring Harbor Laboratory))